Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Total Non-Current Liabilities ₹97 Cr₹84 Cr₹126 Cr₹45 Cr

What is the latest Total Non-Current Liabilities ratio of CORONA REMEDIES ?

The latest Total Non-Current Liabilities ratio of CORONA REMEDIES is ₹97 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹97 Cr
Mar2025₹84 Cr
Mar2024₹126 Cr
Mar2023₹45 Cr

How is Total Non-Current Liabilities of CORONA REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹97 Cr
15.70
Mar2025 ₹84 Cr
-33.38
Mar2024 ₹126 Cr
180.69
Mar2023 ₹45 Cr -

Compare Total Non-Current Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,945.9 Cr -4.5% 0.4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-4.5%

0.4%

NA
SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses